Stan Wang, MD, PhD, is CEO & Founder of Thymmune Therapeutics, a biotechnology company developing a machine learning-enabled thymic cell engineering platform to restore normal immune function in aging and disease. Dr. Wang received his PhD in stem cell biology & regenerative medicine from the University of Cambridge as a Gates Scholar and NIH-Cambridge Scholar, and his MD from Columbia University via the NIH Medical Scientist Training Program. He was a postdoctoral fellow with George Church at Harvard Medical School.

Read more.

Professor Eilís Ferran, FBA PhD is Professor of Company and Securities Law at the University of Cambridge, and the Tom Ivory Professorial Fellow of St Catharine’s College, Cambridge. Eilís has written extensively on UK, EU and international financial regulation, company law and corporate finance law. Her publications include Brexit and Financial Services (Hart Publishing, 2018 (co-authored), The Oxford Handbook of Financial Regulation (OUP, 2015, co-edited) Principles of Corporate Finance Law (OUP, 2014, co-authored) and The Regulatory Aftermath of the Global Financial Crisis (CUP 2012, co-authored). She has advised UK Parliamentary committees and served as an academic member of the Stakeholder Group of the European Banking Authority. She is a non-executive director of Euroclear SA/NV and is the Chair of its Nominations and Governance Committee. Eilís is a Fellow of the British Academy and an Honorary Bencher of Middle Temple. Between 2012 and 2015 she served as Chair of the Law Faculty. Between 2015 and 2021 she was the University's Pro Vice Chancellor for Institutional and International Relations. In that role, she was the academic strategic lead for staff and for significant international partnerships, led the modernisation of career paths, oversaw the University's response as an employer to COVID-19, and was instrumental in the establishment of the Strategic Partnerships Office.

Read more.